Phase 4 N=20 Diagnostic

Stress Testing and Cardiac Magnetic Resonance

Coronary Disease

Bottom Line

View on ClinicalTrials.gov: NCT00871260 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Jun 2021

Primary outcome: Primary: Major Adverse Cardiovascular Events — 0 Participants

Study Design & Population

Study type: Interventional
Phase: Phase 4
Interventions: regadenoson (Drug)
Age: Adult, Older Adult · 18+ yrs
Sex: All
Sponsor: University of Chicago
Primary completion: Jun 2014

Outcome Measures

Outcome	Result	p-value
PRIMARY Major Adverse Cardiovascular Events	—	—
SECONDARY Relationship Between SPECT and CMR Results of Myocardial Perfusion Imaging	—	—
SECONDARY Optimization of Coronary Imaging Using CMR	—	—

Summary

The purpose of this study is to better define the role of a comprehensive stress MRI (which includes myocardial perfusion imaging, optimized coronary imaging, and myocardial scar imaging) in medical practice and in patient health management. Information gathered from the healthy volunteers that participate in this study will be compared to information from the coronary artery disease patients in this study in order to help further our understanding.

Eligibility Criteria

Inclusion Criteria

Suspected coronary artery disease
Symptoms of possible coronary artery disease

Exclusion Criteria

Acute ST-elevation myocardial infarction
Second or third degree AV block
Severe Renal Disease (Glomerular Filtration Rate (GFR) <30cc/min or hemodialysis)
Contra-indications to MRI (i.e. Implantable Cardioverter Defibrillator (ICD), pacemaker, aneurysm clip, etc)
Hemodynamic instability
Inability to provide informed consent
Severe claustrophobia
Pregnancy
Age <18 years

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT00871260). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.